lowering effect
Showing 1 - 25 of >10,000
Hyperlipidemias Trial in Belfast (Fenugreek Seed Tea, Black Tea)
Recruiting
- Hyperlipidemias
- Fenugreek Seed Tea
- Black Tea
-
Belfast, Northern Ireland, United Kingdom
- +1 more
May 5, 2023
Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)
Recruiting
- Breast Cancer Invasive
- Leuplin or zoladex
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 16, 2022
Primary Open Angle Glaucoma, Intraocular Pressure, Glaucoma Surgery Trial (High frequency deep sclerotomy (HFDS))
Not yet recruiting
- Primary Open Angle Glaucoma
- +2 more
- High frequency deep sclerotomy (HFDS)
- (no location specified)
Aug 15, 2022
Hypertension Trial in Boston (Sleep Extension, Sleep Timing)
Active, not recruiting
- Hypertension
- Sleep Extension
- Sleep Timing
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
May 20, 2022
Telenursing Lipid Lowering Medication Adherence Trial (SMS reminder massages about adherence)
Not yet recruiting
- Telenursing Lipid Lowering Medication Adherence
- SMS reminder massages about adherence
- (no location specified)
May 15, 2023
High Myopia, Glaucoma, Suspect Trial in Guangzhou (Assigned Interventions: IOP-lowering eye drops)
Not yet recruiting
- High Myopia
- Glaucoma, Suspect
- Assigned Interventions: IOP-lowering eye drops
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Apr 29, 2023
Hypercholesterolemia Trial (MK0653, ezetimibe / Duration of Treatment: 4 Weeks)
Completed
- Hypercholesterolemia
- MK0653, ezetimibe / Duration of Treatment: 4 Weeks
- (no location specified)
Feb 7, 2022
Chronic Kidney Diseases, Hyperphosphatemia Trial in Chengdu (AP-306, Sevelamer Carbonate)
Recruiting
- Chronic Kidney Diseases
- Hyperphosphatemia
- AP-306
- Sevelamer Carbonate
-
Chengdu, Sichuan, ChinaSichuan Provincial People's Hospital
Mar 9, 2023
Hypercholesterolemia Trial in Helsinki (Plant stanol ester, Placebo)
Active, not recruiting
- Hypercholesterolemia
- Plant stanol ester
- Placebo
-
Helsinki, FinlandNightingale Health plc
Dec 2, 2021
Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)
Active, not recruiting
- Above Optimal Plasma LDL Concentrations
- muffin
-
Winnipeg, Manitoba, Canada
- +1 more
Oct 24, 2022
Adverse Effect of Cardiovascular Medications (Diagnosis) Trial in Zibo (Evolocumab combined with statins, Statin)
Recruiting
- Adverse Effect of Cardiovascular Medications (Diagnosis)
- Evolocumab combined with statins
- Statin
-
Zibo, Shandong, ChinaZibo Central Hospital
Mar 24, 2023
Hypercholesterolemia Trial in Helsinki (Product that contains plant stanol ester, Placebo product)
Completed
- Hypercholesterolemia
- Product that contains plant stanol ester
- Placebo product
-
Helsinki, FinlandNightingale Health plc
Dec 2, 2021
Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost SR
- LUMIGAN
-
Dothan, Alabama
- +5 more
May 17, 2022
Statin, Risk Factors, Primary Prevention Trial in Nanjing (Coronary Computed Tomography Angiography, No Intervention)
Not yet recruiting
- Statin
- +2 more
- Coronary Computed Tomography Angiography
- No Intervention
-
Nanjing, Jiangsu, ChinaResearch Institute Of Medical Imaging Jinling Hospital
Feb 15, 2023
Dyslipidemias Trial in Samara (Combined Lipid-lowering Therapy)
Recruiting
- Dyslipidemias
- Combined Lipid-lowering Therapy
-
Samara, Russian FederationSamara Regional Cardiology Dispansery
Nov 17, 2022
Hypercholesterolemia Trial in Jaipur (Cardio-complement)
Completed
- Hypercholesterolemia
- Cardio-complement
-
Jaipur, Rajasthan, IndiaGyansanjeevani
Jul 16, 2021
Glaucoma, Suspect, High Myopia Trial in Guangzhou (IOP lowering eye drops)
Recruiting
- Glaucoma, Suspect
- High Myopia
- IOP lowering eye drops
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
May 4, 2022
Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator : rosuvastatin calcium, Comparator: Placebo (unspecified))
Completed
- Hypercholesterolemia
- ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Feb 7, 2022
ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])
Not yet recruiting
- ST Elevation Myocardial Infarction (STEMI)
- Rosuvastatin 20 mg
- Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
- (no location specified)
Feb 1, 2023
Diabetic Peripheral Neuropathy Trial in Wenzhou (hypoglycemic Agents(metformin), lipid-lowering drug(Statin))
Recruiting
- Diabetic Peripheral Neuropathy
- hypoglycemic Agents(metformin)
- lipid-lowering drug(Statin)
-
Wenzhou, Zhejiang, ChinaFirst Affiliated Hospital of Wenzhou Medical University
Sep 11, 2023
Hypercholesterolemia Trial in Edmonton (Kefir)
Completed
- Hypercholesterolemia
- Kefir
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jan 11, 2023
Acute Coronary Syndrome, Myocardial Infarction, Ischemic Stroke Trial in Dudley (Decision Support System (DSS))
Recruiting
- Acute Coronary Syndrome
- +2 more
- Decision Support System (DSS)
-
Dudley, West Midlands, United KingdomRussell's Hall Hospital
Apr 25, 2023
"My A:Care" and "Smart Coach" on Lipid-lowering Treatment
Recruiting
- Dyslipidemia
- My A:care
- Smart Coach
-
Khon Kaen, ThailandChatlert Mueang Pongchaiyakul
May 9, 2022
Blood Pressure Trial in Coleraine (Riboflavin, Folic acid, Placebo)
Completed
- Blood Pressure
- Riboflavin
- +2 more
-
Coleraine, Co.Londonderry, United KingdomHuman Intervention Studies Unit, Ulster University
Jun 11, 2021